Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05923164
What this trial is testing

Reliability And Validity Study Of "The Evaluation Tool For Myofascial Adhesions In Patients After Breast Cancer" In Turkish Language

Who this might be right for
Breast CancerUpper Extremity DysfunctionTissue Adhesion
Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey 88
Not applicableStudy completedNCT01244087
What this trial is testing

Pilot Clinical Trial (Phase II) of Inquiry-based Stress Reduction (IBSR) Program for Survivors of Breast Cancer

Who this might be right for
Inquiry Based Stress Reduction
Tel-Aviv Sourasky Medical Center 30
Not applicableUnknownNCT02488187
What this trial is testing

Comparison of Preoperative ABUS and MRI in Newly Diagnosed Breast Cancer Patients

Who this might be right for
Breast Cancer
University of Kansas Medical Center 115
Testing effectiveness (Phase 2)Active Not RecruitingNCT03377387
What this trial is testing

Capecitabine 7/7 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast Cancer

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 34
Early research (Phase 1)Study completedNCT04572295
What this trial is testing

E7090 as Monotherapy and in Combination With Other Anticancer Agents in Participants With Estrogen Receptor Positive (ER+) and Human Epidermal Growth Receptor 2 Negative (HER2-) Recurrent/Metastatic Breast Cancer

Who this might be right for
Breast Neoplasms
Eisai Co., Ltd. 51
Not applicableStudy completedNCT01488357
What this trial is testing

Patient Preferences for Breast Reconstruction After Mastectomy

Who this might be right for
Breast Cancer
UNC Lineberger Comprehensive Cancer Center 145
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650401
What this trial is testing

Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options

Who this might be right for
Solid TumorsCNS Tumors
Hoffmann-La Roche 69
Large-scale testing (Phase 3)Enrolling By InvitationNCT05645536
What this trial is testing

Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study

Who this might be right for
Breast Cancer
Tolmar Inc. 250
Not applicableStudy completedNCT04257799
What this trial is testing

Lumpectomy Specimen Margin Evaluation With Tomography and Structured Light Imaging

Who this might be right for
Breast Cancer Female
Dartmouth-Hitchcock Medical Center 100
Testing effectiveness (Phase 2)Study completedNCT02687490
What this trial is testing

Abraxane in Patients With Visceral Metastases Dominant Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Fudan University 81
Not applicableStudy completedNCT01598597
What this trial is testing

An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite)

Who this might be right for
Breast CancerColorectal CancerNon-Small Cell Lung Cancer+2 more
Genentech, Inc. 276
Early research (Phase 1)UnknownNCT05989724
What this trial is testing

A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorBreast CancerPancreatic Cancer+2 more
Qurgen Inc. 150
Early research (Phase 1)Study completedNCT00372424
What this trial is testing

Study Of SU011248 In Combination With Docetaxel And Trastuzumab In Patients With Advanced Breast Cancer HER-2 Positive

Who this might be right for
Breast Cancer
Pfizer 26
Not applicableActive Not RecruitingNCT05926024
What this trial is testing

Long-Term Follow-Up in Women With Early Breast Cancer Three Years of More Post Primary Treatment

Who this might be right for
Breast Cancer
UNC Lineberger Comprehensive Cancer Center 253
Large-scale testing (Phase 3)Study completedNCT00201942
What this trial is testing

PET Imaging to Determine the Role of PET in the Assessment of Regional Disease in Breast Cancer (PET PREDICT Trial)

Who this might be right for
Breast Cancer
Ontario Clinical Oncology Group (OCOG) 336
Early research (Phase 1)Ended earlyNCT01891669
What this trial is testing

PF-06263507 In Patients With Advanced Solid Tumors

Who this might be right for
NeoplasmsCarcinoma, Non Small Cell LungBreast Neoplasms+1 more
Pfizer 26
Not applicableNot Yet RecruitingNCT07497191
What this trial is testing

AMH Dynamic Changes to Predict Ovarian Reserve in Perimenopausal Breast Cancer

Who this might be right for
Breast CancerPerimenopauseOvarian Reserve
Shengjing Hospital 300
Testing effectiveness (Phase 2)Study completedNCT02102490
What this trial is testing

Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread

Who this might be right for
Metastatic Breast Cancer
Eli Lilly and Company 132
Not applicableStudy completedNCT07072013
What this trial is testing

An Indirect Treatment Comparison of the Effectiveness of Ribociclib Combined With Non-steroidal Aromatase Inhibitors vs. Tamoxifen for the Adjuvant Treatment of Premenopausal Women With Hormon Receptor-positive, HER2-negative Early Breast Cancer

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 1,937
Not applicableStudy completedNCT01220960
What this trial is testing

Art Therapy Intervention for Breast Cancer Patients

Who this might be right for
Breast Cancer
Dr. Sarkis Meterissian 64
Next Page